Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 299

Showing 26-50 of 299 citing articles:

ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
Shouyan Deng, Yibo Zhang, Huanbin Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2305-2323.e33
Closed Access | Times Cited: 15
Probiotic significance of Lactobacillus strains: a comprehensive review on health impacts, research gaps, and future prospects
Abdul Bari Shah, Aizhamal Baiseitova, Muhammad Zahoor, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 15
Microbiome bacterial influencers of host immunity and response to immunotherapy
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14
Ginseng polysaccharides ameliorate ulcerative colitis via regulating gut microbiota and tryptophan metabolism
Li Wan, Cheng Qian, Chunmei Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130822-130822
Open Access | Times Cited: 13
Cancer immunometabolism: advent, challenges, and perspective
Qin Dang, Borui Li, Bing Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria
Linfu Chen, Zheyu Kang, Jingjing Shen, et al.
Science Bulletin (2024) Vol. 69, Iss. 16, pp. 2565-2579
Closed Access | Times Cited: 13
Effect of structural features on the antitumor activity of plant and microbial polysaccharides: A review
Shiwei Li, Ziyan Zhao, Zeng‐Yang He, et al.
Food Bioscience (2024) Vol. 61, pp. 104648-104648
Closed Access | Times Cited: 13
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation
Mengfan Li, Yiyun Ding, Jingge Wei, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 12
Engineered bacteria in tumor immunotherapy
Hua Chen, Yinrui Zhu, Chonghai Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216817-216817
Closed Access | Times Cited: 11
Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses
Nannan Li, Lili Niu, Yao Liu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma
Chen Xue, Xinyu Gu, Qingmiao Shi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Kai-xin-san improves cognitive impairment in D-gal and Aβ25-35 induced ad rats by regulating gut microbiota and reducing neuronal damage
Huijuan Wang, Lifen Zhou, Zheng Qin, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118161-118161
Closed Access | Times Cited: 10
Interactions between diet and gut microbiota in cancer
Geicho Nakatsu, Natalia Andreeva, M. Macdonald, et al.
Nature Microbiology (2024) Vol. 9, Iss. 7, pp. 1644-1654
Closed Access | Times Cited: 10
Tumor-resident microbes: the new kids on the microenvironment block
Le Li, Vidhi Chandra, Florencia McAllister
Trends in cancer (2024) Vol. 10, Iss. 4, pp. 347-355
Open Access | Times Cited: 9
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
The role of microbial indole metabolites in tumor
Dingjiacheng Jia, Zheng Kuang, Liangjing Wang
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy
Brian D. Griffith, Timothy L. Frankel
Cancers (2024) Vol. 16, Iss. 3, pp. 472-472
Open Access | Times Cited: 8
The tryptophan metabolic pathway of the microbiome and host cells in health and disease
Kentaro Miyamoto, Tomohisa Sujino, Takanori Kanai∥
International Immunology (2024)
Open Access | Times Cited: 8
Limosilactobacillus reuteri - a probiotic gut commensal with contextual impact on immunity
Amanda Lee, David Álvarez Jiménez, Marlies Meisel
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 1
Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Cancer Management and Research (2025) Vol. Volume 17, pp. 171-192
Open Access | Times Cited: 1
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
Jianzhou Chen, Antonin Lévy, Ai-Ling Tian, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 361-379.e10
Open Access | Times Cited: 1
The Tryptophan Metabolite Indole-3-Carboxaldehyde Alleviates Mice with DSS-Induced Ulcerative Colitis by Balancing Amino Acid Metabolism, Inhibiting Intestinal Inflammation, and Improving Intestinal Barrier Function
Mingfei Liu, Yuxuan Wang, Haixin Xiang, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3704-3704
Open Access | Times Cited: 20
Akkermansia muciniphila: A potential target and pending issues for oncotherapy
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 20
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors
Laura Joachim, Sascha Göttert, Anna Sax, et al.
EBioMedicine (2023) Vol. 97, pp. 104834-104834
Open Access | Times Cited: 19

Scroll to top